• Users Online: 303
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 8  |  Issue : 3  |  Page : 247-250

CYP2C9 genotype and phenotype profile of cross-country skiing athletes


1 Department of Medical Biology and Genetics, Faculty of Dentistry, Marmara University, Istanbul, Turkey
2 Laboratory of Medical Genetics and Molecular Diagnostics, Faculty of Engineering and Natural Sciences, Uskudar University, Istanbul, Turkey
3 Mus Alpaslan University, Department of Physical Education and Sports, Mus, Turkey

Correspondence Address:
Beste Tacal Aslan
Department of Medical Biology and Genetics, Faculty of Dentistry, Marmara University, Maltepe, Istanbul
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jnbs.jnbs_36_21

Rights and Permissions

Aim: Most tissues in the body contain cytochrome P450 enzymes, which play an important role in many functions, especially metabolizing drugs and other xenobiotics. The CYP2C9 gene in humans codes for an enzyme called CYP2C9. The goal of this study was to figure out the genotype and allele distributions of the CYP2C9 gene rs1799853 (CYP2C9*2), rs1057910 (CYP2C9*3), rs28371686 (CYP2C9*5) and rs28371685 (CYP2C9*11) polymorphism in our cohort study. Materials and Methods: For this purpose, 19 cross-country skiing athletes took part in our research. After DNAs were extracted from buccal epithelial cells, real-time polymerase chain reaction was used to genotype them. Results: When we looked at the genotype distributions, we found that, the CC genotype was higher than CT and TT genotype for CYP2C9*2. For CYP2C9*3, the AA genotype was higher than the AC genotype and no CC genotype was found. Besides for the CYP2C9*5, only the CC genotype was found. In addition, only the CC genotype was found for CYP2C9*11. For The genotypic and predictive phenotype distribution of CYP2C9 polymorphisms, it was determined that 11 athletes (57.9%) were *1/*1 (extensive metabolizers), and 5 athletes (26.3%) were *1/*2 (intermediate metabolizers). As a poor metabolizer, one athlete *2/*2 (5.3%) and two athlete *2/*3 (10.5%) were determined. Conclusion: This study is the first study investigating the relationship between the CYP2C9 polymorphism in Turkish cross-country skiing athletes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed107    
    Printed4    
    Emailed0    
    PDF Downloaded23    
    Comments [Add]    

Recommend this journal